System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Anna Sapino is an expert in Oncology at University of Turin (Italy). As of July 2026, ScienceLeadR ranks Anna Sapino in the top 1% of experts worldwide for Breast Diseases and Breast Neoplasms. Anna Sapino has authored 499 publications, the most recent in 2026, and is an investigator in 2 clinical trials. SLR score: 1,389 (community average: 125). How the SLR is computed.

LeadR Profile

Anna Sapino University of Turin Italy
1 389 ScienceLeadR Reputation 1389

Unlock

Register Login
Network Map

Oncology

Subspecialties: Hematology - Nutrition - Biochemistry

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Short Biography

She is recognised for her work on breast pathology. The key objectives of her scientific work are twofold: (i) improving the quality of diagnostic tests and innovating pathological diagnosis;

(ii) identifying and validating new biomarkers to enable a more personalised therapeutic approach, as well as improving the outcomes of established biomarkers for targeted therapy

The results of her studies have been presented at national and international meetings and published in peer-reviewed international journals. She has also lectured extensively at national and international meetings.


Organizations

Career arc: 1987 - 2026
Source: PubMed

University of Turin

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 499

Citations

Citations: 18 400 1st author: 41 Last author: 72 Unique author: 2

Main journals

Cancer Res 25
Pathologica 21
Virchows Arch 21
Histopathology 17
Ann Oncol 16

Best Journals

J Clin Oncol 4
Ann Oncol 2
JAMA Oncol 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Effects of lactoferrin-enriched dairy product on iron status in women with gestational diabetes mellitus.
PMID 42448694 — diabetes mellitus, diabetes, gestational, pregnancy, dairy products, lactoferrin, ferritins, yogurt, microbiota		NPJ Sci Food20260
Evaluating total tumor load (TTL) to predict metastasis in four or more axillary lymph nodes in HR +/HER2- breast cancer patients: the TULIP4N + study.
PMID 42250186 — lymph nodes, breast neoplasms, neoplasms, tumor burden, neoplasm metastasis, lymph, breast		Clin Transl Oncol20260
Taste alterations in breast cancer patients undergoing chemotherapy: an observational study.
PMID 42099765 — dysgeusia, breast neoplasms, neoplasms, taste perception, feeding behavior, perception, drug therapy, breast, taste, chemotherapy		Front Nutr20260
World Health Organization classification of tumours of the breast 6th edition 2026.
PMID 42011085 — mucins, pathology, classification, biomarkers, breast, histology, diagnosis, therapeutics		Histopathology20260
Genome-wide biomarker analysis across the full spectrum of HER2-expressing breast cancers to reveal a clonal chromosome 17 imbalance defining unfavourable HER2-low disease.
PMID 41998762 — breast neoplasms, genome, biomarkers, breast, chromosomes, human, pair 17, chromosomes		Biomark Res20260

Clinical Studies 2

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

Phase 2 2

By status:

Completed 1
Unknown 1

By type:

Interventional 2

By Monocentric/Multicentric:

monocentric 0
multicentric2to4 1
multicentric5to9 1
multicentricup10 0

Main Topics

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS